10x Genomics, Inc. Form 8-K Summary
Business Context and Reporting Period
10x Genomics, Inc. filed this Current Report on Form 8-K on February 17, 2021, under Item 2.02 to announce financial results for the fourth quarter and full year ended December 31, 2020.
Financial Results and Key Metrics
The filing states that the company issued a related earnings press release, but the provided filing text does not include the release’s revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.
Changes Versus Prior Comparable Period
The filing text does not provide comparative results or quantify changes from the fourth quarter or full year of 2019.
Guidance, Outlook, Risks, and Unusual Items
The provided text does not include management guidance, outlook commentary, risk disclosures, contingencies, or unusual items. It only references the separate press release attached as Exhibit 99.1.
Important Facts to Verify
- Obtain and review Exhibit 99.1 for the reported fourth-quarter and full-year 2020 financial results.
- Verify revenue, gross margin, operating expenses, net loss, adjusted metrics, cash flow, cash and investments, and debt balances.
- Review any 2021 guidance, operating commentary, and discussion of COVID-19 or other business risks in the press release.
- Note that the results information furnished under Item 2.02 is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference except where expressly stated.